Darolutamide
Product Description
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
Categories
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)
-
Product Cladribine
Oncology API USP, EP, YBHUSDMF, CN Status(A) -
Product Cyclophosphamide
Oncology APIUSP, EP, ChP+YBH
USDMF, CN Status(A) -
Product Cycloserine
Anti-infection APIYBH
-
Product Cytarabine HCl
Oncology API ChP+YBHCN Status(A) -
Product Dalbavancin
Therapeutic Area: Infection
Status: Early
-
Product Daprodustat
Therapeutic Area: Anemia of CKD
Status: Early
-
Product Daunorubicin HCl
Oncology APIUSP, EP, IP, ChP+YBH
USDMF, CEP, CN Status(A) -
Product Demeclocycline HCl
Intermediate -
Product Donepezil HCl
USP, ChP+YBYUSDMF, CN Status(A) -
Product Echinocandin B for Anidulafungin
Intermediate -
Product Eltrombopag Olamine
YBYCN Status(A) -
Product Emodepside
API for Animal HealthIn house
US(Submitted)